Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain
- 21 June 2001
- journal article
- conference paper
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 21 (4) , 277-288
- https://doi.org/10.1016/s0891-0618(01)00115-6
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Drosophila model of Parkinson's diseaseNature, 2000
- A commentary on glial cell line-derived neurotrophic factor (GDNF): From a glial secreted molecule to gene therapyBiochemical Pharmacology, 1999
- Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s diseaseZeitschrift für Neurologie, 1998
- Tyrosine hydroxylase and Parkinson's diseaseMolecular Neurobiology, 1998
- Tyrosine kinase B messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization studyNeuroscience, 1998
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- GDNF is an age-specific survival factor for sensory and autonomic neuronsNeuron, 1995
- Biochemistry of Parkinson's disease with special reference to the dopaminergic systemsMolecular Neurobiology, 1994
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960